1-54757832-G-A

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_152268.4(PARS2):​c.1330C>T​(p.Pro444Ser) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)

Consequence

PARS2
NM_152268.4 missense

Scores

1
2
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 5.17

Publications

0 publications found
Variant links:
Genes affected
PARS2 (HGNC:30563): (prolyl-tRNA synthetase 2, mitochondrial) This gene encodes a putative member of the class II family of aminoacyl-tRNA synthetases. These enzymes play a critical role in protein biosynthesis by charging tRNAs with their cognate amino acids. This protein is encoded by the nuclear genome but is likely to be imported to the mitochondrion where it is thought to catalyze the ligation of proline to tRNA molecules. Mutations have been found in this gene in some patients with Alpers syndrome. [provided by RefSeq, Mar 2015]
PARS2 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 75
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • mitochondrial disease
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.20460218).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_152268.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PARS2
NM_152268.4
MANE Select
c.1330C>Tp.Pro444Ser
missense
Exon 2 of 2NP_689481.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PARS2
ENST00000371279.4
TSL:1 MANE Select
c.1330C>Tp.Pro444Ser
missense
Exon 2 of 2ENSP00000360327.3Q7L3T8
PARS2
ENST00000887740.1
c.1330C>Tp.Pro444Ser
missense
Exon 2 of 2ENSP00000557799.1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
32
GnomAD4 genome
Cov.:
32

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Inborn genetic diseases (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.090
T
BayesDel_noAF
Benign
-0.37
CADD
Benign
21
DANN
Benign
0.97
DEOGEN2
Benign
0.044
T
Eigen
Uncertain
0.30
Eigen_PC
Uncertain
0.41
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Benign
0.79
T
M_CAP
Benign
0.0075
T
MetaRNN
Benign
0.20
T
MetaSVM
Benign
-0.92
T
MutationAssessor
Benign
1.9
L
PhyloP100
5.2
PrimateAI
Benign
0.33
T
PROVEAN
Benign
-1.9
N
REVEL
Benign
0.13
Sift
Benign
0.23
T
Sift4G
Benign
0.72
T
Polyphen
0.42
B
Vest4
0.33
MutPred
0.35
Gain of glycosylation at P444 (P = 0.1419)
MVP
0.082
MPC
0.23
ClinPred
0.45
T
GERP RS
5.7
Varity_R
0.074
gMVP
0.28
Mutation Taster
=76/24
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

hg19: chr1-55223505; COSMIC: COSV64883502; API